Okta insider files notice to sell 10000 shares

An affiliate of Okta filed a Form 144 notice to sell 10000 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.

Rhea-AI Filing Summary

An affiliate of Okta filed a Form 144 notice to sell 10000 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ exchange. The planned sale has an aggregate market value of 935700.00 and occurs against a total of 169459250 shares outstanding.

The securities to be sold were acquired from the issuer as restricted stock units on several dates, including 03/15/2024 (364 shares), 06/15/2024 (8645 shares), and 09/15/2019 (991 shares), matching the 10000 shares covered by the notice. By signing, the seller represents they are not aware of any undisclosed material adverse information about Okta.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Okta (OKTA) disclose in this Form 144 notice?

The filing discloses that an Okta affiliate plans to sell 10000 common shares on NASDAQ with an aggregate market value of 935700.00, using Morgan Stanley Smith Barney LLC as broker.

How many Okta (OKTA) shares are planned to be sold and on which exchange?

The notice covers the proposed sale of 10000 common shares of Okta on the NASDAQ stock market.

What is the aggregate market value of the Okta shares in this Form 144?

The 10000 Okta common shares covered by the notice have an aggregate market value of 935700.00 as stated in the filing.

How many Okta (OKTA) shares are outstanding in this Form 144 context?

The filing reports that there are 169459250 Okta common shares outstanding in connection with this proposed sale.

How were the Okta shares in this Form 144 originally acquired?

The shares were acquired from the issuer as restricted stock units on dates including 03/15/2024 (364 shares), 06/15/2024 (8645 shares), and 09/15/2019 (991 shares).

What representation does the seller make in this Okta Form 144 filing?

The seller represents that they do not know any material adverse information about Okta’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/13/2026 - 04:22 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001865084
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OKTA, INC
SEC File Number	001-38044
Address of Issuer	100 First Street, Suite 600 San Francisco CALIFORNIA 94105
Phone	8887227871
Name of Person for Whose Account the Securities are To Be Sold	BRETT TIGHE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	935700.00	169459250	01/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2024	Restricted Stock Units	Issuer			364	03/15/2024	N/A
Common	06/15/2024	Restricted Stock Units	Issuer			8645	06/15/2024	N/A
Common	09/15/2019	Restricted Stock Units	Issuer			991	09/15/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brett Tighe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)